← Leaderboards
Ling Li
Beckman Research Institute/City Of Hope
$7,488,116
Attributed
$7,488,116
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,488,116 · 6
By mechanism
R01$6,460,612 · 4
R00$746,998 · 1
K99$280,506 · 1
Top collaborators
No co-investigators on record.
Most similar at Beckman Research Institute/City Of Hope
Same institution · by research overlap
- Chun-Wei David Chen$8,071,175
- Jianjun Chen$21,393,583
- Leo D. Wang$847,800
- Guido Marcucci$19,718,636
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTransplantationMouse ModelHematologic NeoplasmsMutationRelapseTargeted TreatmentMediatingKnockout MiceMaintenanceCell MaintenanceGeneticAcute Myelocytic LeukemiaGrowthLeukemiaSignal TransductionMll-Af9MolecularOverexpressionEffective TherapyIn VivoCell GrowthLeadBase
Grant awards (18)
Targeting AMP Synthesis to Overcome Resistance to BH3 Mimetics in Acute Myeloid Leukemia$734,435
R01 · FY2025 · CA · contact PI
Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia$708,057
R01 · FY2025 · CA · contact PI
Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia$727,057
R01 · FY2024 · CA · contact PI
Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance$411,841
R01 · FY2024 · CA · contact PI
Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance$424,845
R01 · FY2023 · CA · contact PI
Targeting protein acetylation as a therapeutic approach for MDS$432,500
R01 · FY2022 · HL · contact PI
Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance$424,845
R01 · FY2022 · CA · contact PI
Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance$433,516
R01 · FY2021 · CA · contact PI
Targeting protein acetylation as a therapeutic approach for MDS$432,500
R01 · FY2021 · HL · contact PI
Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance$433,516
R01 · FY2020 · CA · contact PI
Targeting protein acetylation as a therapeutic approach for MDS$432,500
R01 · FY2020 · HL · contact PI
Targeting protein acetylation as a therapeutic approach for MDS$432,500
R01 · FY2019 · HL · contact PI
Targeting protein acetylation as a therapeutic approach for MDS$432,500
R01 · FY2018 · HL · contact PI
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3$248,999
R00 · FY2017 · CA · contact PI
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3$248,999
R00 · FY2016 · CA · contact PI
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3$249,000
R00 · FY2015 · CA · contact PI
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3$140,253
K99 · FY2015 · CA · contact PI
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3$140,253
K99 · FY2014 · CA · contact PI